Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Sareum Holdings

    MCap

    GBP35m

    Last close

    GBP0.34

    ▲ 10.25 (44.09%)

    Pharnext

    MCap

    1m

    Last close

    EUR0.10

    ▲ 0.03 (42.86%)

    VolitionRx

    MCap

    USD70m

    Last close

    USD0.85

    ▲ 0.25 (41.67%)

  • Sectors

    Sectors

  • Investment Strategy

    Investment Strategy

    View All

    Latest

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

ArborGen Holdings (NZX: ARB)

Last close As at 23/04/2024

NZD0.16

— 0.00 (0.00%)

Market capitalisation

NZD88m

ArborGen Holdings is a New Zealand-listed investment company and is the world’s largest integrated developer, commercial manufacturer and supplier of advanced forestry seedlings with operations in the United States and Brazil.

Prior to the COVID-19 outbreak, the economic growth outlook in each of its core countries, the United States and Brazil, was either good or improving, according to OECD data. At this point the primary end-markets served by ArborGen’s plantation forestry customer base were in a positive cyclical phase.

Latest Insights

View More

Industrials | Update

ArborGen Holdings — Mixed trading, but solid long-term growth outlook

Industrials | Outlook

ArborGen Holdings — Green shoots appear in the spring

Industrials | Update

ArborGen Holdings — Seedling supplier’s long-term future looks green

Industrials | Update

ArborGen Holdings — Shifting focus to US South and Brazil
forestry04
Visit Website

Sector

Industrials

Equity Analyst

Andy Murphy

Andy Murphy

Director, Financials & Industrials

Max Hayes

Max Hayes

Associate Analyst

Natalya Davies

Natalya Davies

Analyst

Key Management

  • Alex Brown

    CFO

  • Dave Knott, Jr

    Chairman

  • Justin Birch

    President and CEO

  • Sharon Ludher-Chandra

    Business Development Executive

Balance Sheet

Forecast net debt (US$m)

N/A

Forecast gearing ratio (%)

N/A

Share Price Performance

Price Performance
% 1M 3M 12M
Actual 9.3 2.5 (13.7)
Relative 10.6 2.1 (10.3)
52 week high/low 0.2/0.2

Financials

ArborGen’s H124 results highlighted contrasting trading conditions, with challenges in the US offset by a strong performance from Brazil. However, despite the short-term issues, ArborGen remains in prime position to address increasing demand for its seedlings and to continue investment in genetic improvement to drive the switch to sales of higher-value, higher-margin seedlings in both markets. While this process plays out, underlying EBIT is set to increase fivefold in the next two years as we expect gross margins to return to and then exceed historical levels. However, the recent US weakness has led us to trim our DCF valuation from NZ$0.49/share to NZ$0.44, still implying material upside.

Y/E Mar Revenue (US$m) EBITDA (US$m) PBT (US$m) EPS (fd) (c) P/E (x) P/CF (x)
2022A 47.6 10.1 1.0 1.1 8.6 4.4
2023A 56.1 9.2 0.3 (0.6) N/A 21.7
2024E 64.8 12.0 3.0 0.6 15.8 15.4
2025E 71.3 16.1 7.2 1.0 9.5 4.5

Update

Industrials

Rubicon — Growth to come after FY19 challenges

Update

Industrials

Rubicon — Well-positioned going into H2

Initiation

Industrials

Rubicon — Pure play, clear focus